Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
Add more filters










Publication year range
1.
Brain Stimul ; 8(1): 57-63, 2015.
Article in English | MEDLINE | ID: mdl-25457212

ABSTRACT

BACKGROUND: Deep brain stimulation (DBS), a form of neurosurgical intervention that is used to modulate the electrophysiological activity of specific brain areas, has emerged as a form of therapy for severe cases of treatment-refractory addiction. OBJECTIVE/HYPOTHESIS: Recent research suggests that the nucleus accumbens (NAC) is a promising target area for DBS in addiction. The current experiments were designed to determine optimal parameters of stimulation and long-term efficacy of NAC DBS in an animal model of cocaine addiction. METHODS: Rats were implanted with a stimulating electrode in the right NAC and exposed to chronic cocaine self-administration (0.5 mg/kg/infusion). Rats underwent drug seeking tests by exposing them to the self-administration context paired with cocaine challenge (5 mg/kg i.p.) on days 1, 15 and 30 after withdrawal from cocaine self-administration. Low-frequency (LF, 20 Hz) or high-frequency (HF, 160 Hz) DBS was applied for 30 min daily for 14 consecutive days starting one day after drug withdrawal. RESULTS: Rats exhibited robust drug-seeking 1, 15 and 30 days after withdrawal from cocaine self-administration, with responding being highest on day 15. Both LF and HF attenuated cocaine seeking on day 15 post-withdrawal by 36 and 48%, respectively. Both forms of stimulation were ineffective on the tests conducted on days 1 and 30. CONCLUSION: The present data showed that unilateral DBS of the NAC effectively attenuated cocaine relapse after 15 days of drug withdrawal, with therapeutic-like effects seemingly diminishing after DBS discontinuation. This evidence provides support for DBS as a promising intervention in intractable cases of stimulant addiction.


Subject(s)
Cocaine-Related Disorders/therapy , Cocaine/administration & dosage , Deep Brain Stimulation , Disease Models, Animal , Drug-Seeking Behavior/physiology , Nucleus Accumbens/physiology , Animals , Cocaine/pharmacology , Cocaine-Related Disorders/prevention & control , Drug-Seeking Behavior/drug effects , Male , Rats , Recurrence , Reinforcement Schedule , Saccharin/administration & dosage , Self Administration
2.
Eur J Pharmacol ; 731: 73-9, 2014 May 15.
Article in English | MEDLINE | ID: mdl-24675149

ABSTRACT

JHW 007 [N-(n-butil)-3α-[bis(4'-fluorophenil)methoxi]-tropane] belongs to the family of N-substituted benztropine (BZT) analogs, atypical dopamine transporter (DAT) blockers that are able to strongly modulate cocaine- and amphetamine-related behavior. In the present study, we tested in rats the ability of JHW 007 to alter the stimulant and reinforcing properties of methamphetamine (METH) using locomotor activity, fixed ratio and progressive ratio (PR) self-administration tests. The results showed that JHW 007 attenuated METH-induced locomotor stimulation in a dose-dependent manner and had no stimulant effects when administered alone. The BZT analog, given as a pre-treatment, attenuated METH self-administration without affecting responding for sucrose. In the PR tests JHW 007 produced an increase of the breaking point achieved for both METH- and sucrose self-administration, suggesting that the ability of the BZT analog to reduce self-administration may be linked to its ability to enhance the reinforcing properties of METH. Taken together, these data suggest that DAT inhibition with a high affinity blocker such as JHW 007 can exert differential effects on METH-associated behaviors, reducing METH-induced motor stimulation but augmenting METH׳s reinforcing effects.


Subject(s)
Benztropine/analogs & derivatives , Dopamine Uptake Inhibitors/pharmacology , Dopamine/metabolism , Methamphetamine/pharmacology , Motor Activity/drug effects , Animals , Benztropine/administration & dosage , Benztropine/pharmacology , Biological Transport/drug effects , Dopamine Uptake Inhibitors/administration & dosage , Dose-Response Relationship, Drug , Male , Methamphetamine/metabolism , Rats , Reinforcement, Psychology , Self Administration , Sucrose/pharmacology
3.
Eur Neuropsychopharmacol ; 20(7): 501-8, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20413276

ABSTRACT

The discovery and evaluation of high affinity dopamine transport inhibitors with low abuse liability is an important step toward the development of efficacious medications for cocaine addiction. We examined in mice the behavioural effects of (N-(n-butyl)-3alpha-[bis(4'-fluorophenyl)methoxy]-tropane) (JHW 007), a benztropine (BZT) analogue that blocks dopamine uptake, and assessed its potential to influence the actions of cocaine in clinically-relevant models of cocaine addiction. In the conditioned place preference (CPP) paradigm, JHW 007 exposure did not produce place conditioning within an ample dose range but effectively blocked the CPP induced by cocaine administration. Similarly, in the CPP apparatus JHW 007 treatment failed to stimulate locomotor activity at any dose but dose-dependently suppressed the hyperactivity evoked by cocaine treatment. In locomotor sensitization assays performed in the open field, JHW 007 did not produce sensitized locomotor behaviour when given alone, but it prevented the sensitized component of the locomotor response elicited by subchronic (8-day) cocaine exposure. In the elevated plus maze (EPM), acute treatment with JHW 007, cocaine and combinations of the BZT analogue and cocaine produced an anxiogenic-like profile. Re-test in the EPM following subchronic (8-day) exposure enhanced the anxiogenic-like effect of the same drug treatments. The present findings indicate that JHW 007 exposure counteracts some critical behavioural correlates of cocaine treatment, including conditioned reward, locomotor stimulation and sensitization, and lend support to the further development of BZT analogues as potential replacement medications in cocaine addiction.


Subject(s)
Benztropine/analogs & derivatives , Cocaine/pharmacology , Dopamine Antagonists/pharmacology , Dopamine Uptake Inhibitors/pharmacology , Motor Activity/drug effects , Reward , Analysis of Variance , Animals , Behavior, Animal/drug effects , Benztropine/pharmacology , Conditioning, Operant/drug effects , Drug Interactions , Male , Maze Learning/drug effects , Mice
4.
Behav Brain Res ; 210(1): 134-9, 2010 Jun 26.
Article in English | MEDLINE | ID: mdl-20153381

ABSTRACT

Stress can induce preferential engagement of habit learning mediated by the basal ganglia, relative to learning that involves complex spatial associations contributed by the hippocampal formation. We explored in mice the influence that chronic episodes of social stress exert on the selection of cognitive/spatial vs. habit-based learning strategies. Male mice were exposed to repeated episodes of social confrontation and were categorized as dominant, subordinate or undetermined according to quantitative ethologically relevant parameters of aggression. Mice were then trained in a conditional discrimination task in the T-maze in the presence of allocentric cues until five correct choices were made. The T-maze was then turned 180 degrees and mice were categorized as "cue-learners" or "place-learners" on the basis of their first response in the probe test. Mice showed a graded preference for place vs. cue learning strategies depending on their social categorization (control>undetermined>dominant>subordinate), which ranged from 55% in controls to only 10% in subordinate mice. The response of subordinate mice differed significantly from controls. Hippocampal neurogenesis was studied in the different groups of mice. In keeping with the tendency to engage habit learning, 2,5-bromodeoxyuridine (BrdU) incorporation in the DG was reduced in mice that experienced agonistic encounters, and so was the expression of doublecortin, a marker for immature neurons. These observations suggest that chronic social stress impairs neurogenesis in the adult hippocampus, weakens spatial learning and strengthens habit-like responses.


Subject(s)
Dominance-Subordination , Habits , Hippocampus/physiopathology , Learning/physiology , Neurogenesis/physiology , Stress, Psychological/physiopathology , Aggression , Animals , Chronic Disease , Cues , Discrimination, Psychological/physiology , Disease Models, Animal , Male , Maze Learning/physiology , Mice , Neuropsychological Tests , Space Perception/physiology
5.
Neuroscience ; 159(1): 59-68, 2009 Mar 03.
Article in English | MEDLINE | ID: mdl-19138728

ABSTRACT

Neurogenesis in the adult dentate gyrus (DG) of the hippocampus has been implicated in neural plasticity and cognition but the specific functions contributed by adult-born neurons remain controversial. Here, we have explored the relationship between adult hippocampal neurogenesis and memory function using tasks which specifically require the participation of the DG. In two separate experiments several groups of rats were exposed to fractionated ionizing radiation (two sessions of 7 Gy each on consecutive days) applied either to the whole brain or focally, aiming at a region overlying the hippocampus. The immunocytochemical assays showed that the radiation significantly reduced the expression of doublecortin (DCX), a marker for immature neurons, in the dorsal DG. Ultrastructural examination of the DG region revealed disruption of progenitor cell niches several weeks after the radiation. In the first experiment, whole-brain and focal irradiation reduced DCX expression by 68% and 43%, respectively. Whole-brain and focally-irradiated rats were unimpaired compared with control rats in a matching-to-place (MTP) working memory task performed in the T-maze and in the long-term retention of the no-alternation rule. In the second experiment, focal irradiation reduced DCX expression by 36% but did not impair performance on (1) a standard non-matching-to-place (NMTP) task, (2) a more demanding NMTP task with increasingly longer within-trial delays, (3) a long-term retention test of the alternation rule and (4) a spatial reversal task. However, rats irradiated focally showed clear deficits in a "purely" contextual fear-conditioning task at short and long retention intervals. These data demonstrate that reduced adult hippocampal neurogenesis produces marked deficits in the rapid acquisition of emotionally relevant contextual information but spares spatial working memory function, the long-term retention of acquired spatial rules and the ability to flexibly modify learned spatial strategies.


Subject(s)
Hippocampus/cytology , Learning/physiology , Memory, Short-Term/physiology , Neural Inhibition/physiology , Neurogenesis/physiology , Retention, Psychology/physiology , Animals , Conditioning, Psychological/physiology , Conditioning, Psychological/radiation effects , Doublecortin Domain Proteins , Doublecortin Protein , Fear/physiology , Fear/radiation effects , Freezing Reaction, Cataleptic/physiology , Freezing Reaction, Cataleptic/radiation effects , Hippocampus/radiation effects , Learning/radiation effects , Male , Maze Learning/physiology , Maze Learning/radiation effects , Memory, Short-Term/radiation effects , Microtubule-Associated Proteins/metabolism , Neural Inhibition/radiation effects , Neurogenesis/radiation effects , Neuropeptides/metabolism , Radiation , Rats , Rats, Long-Evans , Retention, Psychology/radiation effects , Time Factors
6.
Neurobiol Learn Mem ; 90(3): 553-9, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18644245

ABSTRACT

The hippocampus is believed to play a role in processing information relative to the context in which emotionally salient experiences occur but evidence on the specific contribution of the hippocampal dentate gyrus (DG) to these processes is limited. Here, we have used two classical behavioral paradigms to study the participation of the dorsal DG in context-conditioned reward and context-conditioned fear. Rats received intra-hippocampal vehicle or colchicine injections (4 microg/microl solution; 0.2 microl injections at 10 sites) that damaged the DG but spared other hippocampal subfields. In the first experiment, we used a place conditioning procedure pairing cocaine exposure (20 mg/kg, i.p.) with a specific context and vehicle treatment with another. While rats with sham lesions exhibited preference for the cocaine-paired context following conditioning, rats with lesions of the DG showed no evidence of cocaine-induced place preference. In the second experiment, rats with sham or colchicine lesions received a foot shock in a given context and conditioned freezing was measured upon reexposure to the shock-paired context (2, 24, 48 and 96 h after conditioning). Rats with sham lesions exhibited high levels of conditioned freezing when exposed to the conditioning context but rats with lesions of the DG showed impaired conditioning, behaving as controls that had experienced shock in a different context. These observations indicate that the integrity of the DG is essential for establishing a coherent representation of the context to which emotional experiences, either hedonic or aversive, are bound.


Subject(s)
Association Learning/physiology , Dentate Gyrus/physiology , Fear/physiology , Retention, Psychology/physiology , Analysis of Variance , Animals , Association Learning/drug effects , Central Nervous System Agents/pharmacology , Cocaine/pharmacology , Conditioning, Classical/physiology , Dentate Gyrus/drug effects , Exploratory Behavior/physiology , Fear/drug effects , Hippocampus/physiology , Male , Rats , Rats, Long-Evans , Reward
7.
Physiol Behav ; 93(1-2): 206-14, 2008 Jan 28.
Article in English | MEDLINE | ID: mdl-17900634

ABSTRACT

Preexposure to the conditioning context can influence the expression of context-conditioned fear. We used behavioral and early growth response gene (egr-1) assays in rats to study the effects of massed and distributed context preexposure on context-conditioned fear. The results demonstrated that massed context preexposure impaired acquisition of contextual fear, an effect here referred to as delayed shock deficit. Spaced context preexposure produced similar inhibitory effects. Significantly, the introduction of a brief change of context prior to conditioning completely reversed the deficit induced by massed, but not by distributed, context preexposure. This reversibility was inversely related to the duration of the context shift. The acquisition of context-conditioned fear was associated with enhanced Egr-1 expression in the basolateral amygdala (BLA). No such increase was evident in animals undergoing distributed context preexposure or in those experiencing massed preexposure without change of context. Remarkably, a brief change of context prior to conditioning not only facilitated learning following massed preexposure but also elicited a significant elevation of Egr-1 protein levels in the BLA. The findings shown demonstrated that the inhibitory effects of massed and distributed context preexposure on conditioning could be dissociable both behaviorally and physiologically. We suggest that the delayed shock deficit associated with massed preexposure derives from perceptual fade-out or inattention and its reversal by a brief change of context from attentional recovery.


Subject(s)
Amygdala/metabolism , Conditioning, Classical/physiology , Early Growth Response Protein 1/metabolism , Fear/physiology , Habituation, Psychophysiologic/physiology , Inhibition, Psychological , Analysis of Variance , Animals , Association Learning/physiology , Environment , Freezing Reaction, Cataleptic/physiology , Male , Practice, Psychological , Rats , Rats, Sprague-Dawley , Statistics, Nonparametric
8.
Brain Res Bull ; 72(4-6): 315-23, 2007 May 30.
Article in English | MEDLINE | ID: mdl-17452292

ABSTRACT

We studied the cognitive performance of rats with colchicine-induced lesions of the hippocampal dentate gyrus (DG) on a range of spatial, non-spatial and mixed spatial/procedural tasks. Rats were assigned to three experimental groups receiving large colchicine lesions (7 microg per hippocampus), small colchicine lesions (1.75 microg per hippocampus) or sham lesions. Stereological estimates of cell density indicated that the colchicine treatments induced dose-dependent damage to the DG, while sparing in large part other hippocampal subfields. Remarkably, the behavioural results showed that the colchicine lesions did not affect the performance of rats in an object discrimination task, in an object-place associative task in which a familiar object was displaced from a given position nor in a spontaneous spatial discrimination task performed in the T-maze. However, rats in both lesion groups were severely impaired in a reinforced non-matching-to-position working memory task conducted in the T-maze. Importantly, performance in the working memory task correlated strongly with cell density in the DG but not with cell density in the CA1 and CA3 areas. Only rats with large-lesions showed a transient deficit in a reinforced rule-based conditional discrimination task. These data demonstrated that rats with selective lesions of the DG readily acquire and retain neural representations relative to objects and places but are specifically impaired in their ability to update rapidly and flexibly spatial information that is essential to guide goal-directed actions.


Subject(s)
Conditioning, Operant/physiology , Dentate Gyrus/physiology , Memory, Short-Term/physiology , Space Perception/physiology , Analysis of Variance , Animals , Cell Count , Dentate Gyrus/anatomy & histology , Dentate Gyrus/injuries , Discrimination, Psychological/physiology , Exploratory Behavior/physiology , Male , Maze Learning , Neuropsychological Tests , Rats , Rats, Long-Evans , Reward , Statistics as Topic
9.
J Neural Transm (Vienna) ; 114(1): 43-8, 2007 Jan.
Article in English | MEDLINE | ID: mdl-16955373

ABSTRACT

Environmental enrichment produces changes in spontaneous and psychostimulant-induced motor activity. Dopamine in the prefrontal cortex (PFC), through the activation of D1 receptors, has been suggested to play a role in modulating motor activity. The present study investigated the effects of environmental enrichment on spontaneous motor activity, prefrontal acetylcholine release following local D1 receptor stimulation and D1 receptor expression in the PFC. Male wistar rats (3 months of age) were housed in enriched or isolated conditions during 90 days. Animals were then implanted with guide cannulae to perform microdialysis experiments in the PFC. Spontaneous motor activity and acetylcholine extracellular concentrations were monitored simultaneously. Also spontaneous motor activity was measured in an open field. On completion of the experiments, the density of D1 receptors in the PFC was studied by immunocytochemistry. Rats housed in an enriched environment showed significantly lower spontaneous motor activity in the open field compared to isolated animals. Perfusion of the D1 agonist SKF38393 (50 microM; 40 min) in the PFC produced long lasting increases of spontaneous motor activity and of local dialysate concentrations of acetylcholine in both groups of rats. However, increases of both motor activity and acetylcholine concentrations were significantly lower in enriched compared to isolated animals. Moreover, the density of D1 receptors in the PFC was significantly reduced in animals housed in an enriched environment. These results are the first evidence suggesting that environmental enrichment during adult life changes the function of D1 dopamine receptors in the PFC.


Subject(s)
Dopamine/metabolism , Environment, Controlled , Neuronal Plasticity/physiology , Prefrontal Cortex/metabolism , Receptors, Dopamine D1/metabolism , Acetylcholine/metabolism , Animals , Dopamine Agonists/pharmacology , Exploratory Behavior/physiology , Extracellular Fluid/drug effects , Extracellular Fluid/metabolism , Male , Motor Activity/physiology , Presynaptic Terminals/metabolism , Rats , Rats, Wistar , Receptors, Dopamine D1/agonists
10.
Prog Neuropsychopharmacol Biol Psychiatry ; 31(1): 191-9, 2007 Jan 30.
Article in English | MEDLINE | ID: mdl-17023106

ABSTRACT

We tested the ability of 3,4-methylenedioxymethamphetamine (MDMA) to induce conditioned place preference (CPP) in dominant and subordinate OF-1 mice subjected to cohabitation and repeated sessions of agonistic confrontation, as well as in non-confronted mice. We selected doses of MDMA (2, 6, 10 mg/kg) previously reported to induce CPP in mice and we measured expression of c-Fos evoked by the treatments in non-confronted mice. MDMA induced c-Fos protein in several corticolimbic regions involved in drug-induced reward. Mice were exposed to brief sessions of agonistic confrontation on 5 consecutive days. Determinations of circulating hormones and drug conditioning tests were carried out on completion of the encounters. The results of hormone assays indicated that dominant mice had higher serum concentrations of testosterone, but lower levels of corticosterone, than submissive mice. Post-conditioning tests after drug conditioning (4 injections of MDMA or saline on alternate days) showed that MDMA significantly produced CPP at doses of 2 and 6 mg/kg, but not at 10 mg/kg, an inverted U-shaped pattern of conditioning that was invariable in non-confronted, dominant and subordinate mice. These results demonstrate that the endocrine and behavioural correlates linked to social status and social stress in mice are not paralleled by significant changes in the rewarding efficacy of MDMA in the CPP paradigm under the specific conditions tested.


Subject(s)
Conditioning, Operant/drug effects , Dominance-Subordination , N-Methyl-3,4-methylenedioxyamphetamine/pharmacology , Reward , Serotonin Agents/pharmacology , Agonistic Behavior/drug effects , Animals , Corticosterone/blood , Gene Expression/drug effects , Genes, fos/drug effects , Immunohistochemistry , Male , Mice , Social Environment , Stress, Psychological/psychology , Testosterone/blood
11.
Neuropharmacology ; 51(5): 967-73, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16949621

ABSTRACT

3,4-Methylenedioxymethamphetamine (MDMA) is a potent stimulant and hallucinogenic drug whose ability to regulate neurogenesis in the adult has not been previously investigated. We used 5'-bromo-2-deoxyuridine (BrdU) and Ki-67 as mitotic markers, and doublecortin (DCX) as a marker of immature neurons, to study proliferation, survival and maturation of adult-generated cells in the dentate gyrus (DG) of the hippocampus following binge administration of MDMA (8 injections of 5 mg/kg at 6 h intervals). The results showed that MDMA treatment did not affect cytogenesis in the DG, but significantly decreased the survival rate of cells incorporated after 2 weeks to the granular layer of the DG by ca. 50%, and of those remaining in the subgranular layer by ca. 30%. Two weeks after exposure to MDMA the length of dendritic arbors and the number of dendritic branches of immature DCX+ neurons were nearly identical to those of control rats, as was the level of colocalization of BrdU with DCX. These results demonstrate that binge MDMA administration does not affect the proliferation rates of progenitor cells in the DG, but has deleterious effects on adult neurogenesis by impairing the short-term survival of vulnerable neural precursors.


Subject(s)
Dentate Gyrus/pathology , Hallucinogens/administration & dosage , N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage , Neurons/drug effects , Stem Cells/drug effects , Analysis of Variance , Animals , Behavior, Animal/drug effects , Bromodeoxyuridine/metabolism , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Survival/drug effects , Dentate Gyrus/drug effects , Doublecortin Domain Proteins , Doublecortin Protein , Immunohistochemistry/methods , Ki-67 Antigen/metabolism , Male , Microtubule-Associated Proteins/metabolism , Neuropeptides/metabolism , Rats , Rats, Wistar
12.
Eur J Neurosci ; 24(2): 586-94, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16903860

ABSTRACT

Recent observations indicate that drugs of abuse, including alcohol and opiates, impair adult neurogenesis in the hippocampus. We have studied in rats the impact of cocaine treatment (20 mg/kg, daily, i.p.) on cell proliferation, survival and maturation following short-term (8-day) and long-term (24-day) exposure. Using 5'-bromo-2-deoxyuridine (BrdU) and Ki-67 as mitotic markers at the end of the drug treatments, we found that both short- and long-term cocaine exposures significantly reduced cell proliferation in the dentate gyrus (DG) of the hippocampus. By labelling mitotic cells with BrdU pulses before or during the early stages of the drug treatment, we determined that long-term cocaine exposure did not affect the survival of newly generated cells. In register with this finding, cocaine chronic exposure did not increase the number of apoptotic cells labelled by TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling). Using doublecortin (DCX) immunocytochemistry and electron microscopy, we next examined the effects of cocaine exposure on the maturation of the neural precursors and on synaptic output to CA3. DCX immunocytochemistry showed that immature hippocampal cells of rats exposed to cocaine displayed normal arborization patterns and similar degrees of colocalization with BrdU at two different developmental stages. Moreover, cocaine did not produce significant morphological alterations of the mossy fibre projection system to stratum lucidum in the CA3 area of the hippocampus. The results presented demonstrate that chronic cocaine exposure impairs proliferation dynamics in the DG without significantly altering either the survival and growth of immature cells or the structural features of terminal projections to CA3.


Subject(s)
Cocaine-Related Disorders/physiopathology , Cocaine/adverse effects , Dentate Gyrus/drug effects , Neurons/drug effects , Stem Cells/drug effects , Animals , Bromodeoxyuridine , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Proliferation/drug effects , Cell Shape/drug effects , Cell Shape/physiology , Cell Survival/drug effects , Cell Survival/physiology , Chronic Disease , Cognition Disorders/chemically induced , Cognition Disorders/physiopathology , Dentate Gyrus/pathology , Dentate Gyrus/physiopathology , Disease Models, Animal , Dopamine Uptake Inhibitors/adverse effects , Doublecortin Domain Proteins , Doublecortin Protein , Down-Regulation/drug effects , Down-Regulation/physiology , Drug Administration Schedule , Ki-67 Antigen/metabolism , Male , Microtubule-Associated Proteins/drug effects , Microtubule-Associated Proteins/metabolism , Mitosis/drug effects , Mitosis/physiology , Mossy Fibers, Hippocampal/drug effects , Mossy Fibers, Hippocampal/pathology , Neurons/pathology , Neuropeptides/drug effects , Neuropeptides/metabolism , Rats , Rats, Wistar , Stem Cells/pathology
13.
Neurochem Int ; 42(7): 525-33, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12590934

ABSTRACT

2,5-Hexanedione is a neurotoxic metabolite of hexane. The mechanisms of its neurotoxicity remain unclear. We assessed whether chronic exposure to 2,5-hexanedione affects the glutamate-nitric oxide-cGMP pathway in primary cultures of cerebellar neurons and/or in the cerebellum of rats. Chronic exposure of cultured cerebellar neurons to 2,5-hexanedione (200 microM) reduced by approximately 50% NMDA-induced formation of cGMP. Activation of soluble guanylate cyclase by nitric oxide was reduced by 46%. This treatment reduced the content of neuronal nitric oxide synthase and soluble guanylate cyclase in neurons by 23 and 20%, respectively. In the cerebellum of rats chronically exposed to 2,5-hexanedione (in the drinking water) NMDA-induced formation of cGMP was reduced by 55% as determined by in vivo brain microdialysis. Activation of soluble guanylate cyclase by nitric oxide was reduced by 65%. The content of neuronal nitric oxide synthase and of soluble guanylate cyclase was reduced by 25 and 21%, respectively, in the cerebellum of these rats. The effects are the same in both systems, indicating that cultured neurons are a good model to study the mechanisms of neurotoxicity of 2,5-hexanedione. These results indicate that chronic exposure to 2,5-hexanedione affects the glutamate-nitric oxide-cGMP pathway at different steps both in cultured neurons and in cerebellum of the animal in vivo. The alteration of this pathway may contribute to the neurotoxic effects of 2,5-hexanedione.


Subject(s)
Cerebellum/metabolism , Cyclic GMP/metabolism , Glutamic Acid/metabolism , Hexanones/pharmacology , Neurons/metabolism , Neurotoxins/pharmacology , Nitric Oxide/metabolism , Animals , Cells, Cultured , Microdialysis , Rats , Rats, Wistar
14.
Brain ; 125(Pt 10): 2353-63, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12244091

ABSTRACT

Dopamine and glutamate are key neurotransmitters in cortico-basal ganglia loops affecting motor and cognitive function. To examine functional convergence of dopamine and glutamate neurotransmitter systems in the basal ganglia, we evaluated the long-term effects of chronic stimulation of each of these systems on striatal responses to stimulation of the other. First we exposed rats to chronic intermittent cocaine and used early-gene assays to test the responsivity of the striatum to subsequent acute motor cortex stimulation by application of the GABA(A) (gamma-aminobutyric acid alpha subunit) receptor antagonist, picrotoxin. Reciprocally, we studied the effects of chronic intermittent motor cortex stimulation on the capacity for subsequent acute dopaminergic treatments to induce early-gene activation in the striatum. Prior treatment with chronic intermittent cocaine induced motor sensitization and significantly potentiated the striatal expression of Fos-family early genes in response to stimulation of the motor cortex. Contrary to this, chronic intermittent stimulation of the motor cortex down-regulated cocaine-induced gene expression in the striatum, but enhanced striatal gene expression induced by a full D1 receptor agonist (SKF 81297) and did not change the early-gene response elicited by a D2 receptor antagonist (haloperidol). These findings suggests that repeated dopaminergic stimulation produces long-term enhancement of corticostriatal signalling from the motor cortex, amplifying cortically evoked modulation of the basal ganglia. By contrast, persistent stimulation of the motor cortex inhibits cocaine-stimulated signalling in the striatum, but not signalling mediated by individual dopamine receptor sites, suggesting that chronic cortical hyperexcitability produces long-term impairment of dopaminergic activity and compensation at the receptor level. These findings prompt a model of the basal ganglia function as being regulated by opposing homeostatic dopamine-glutamate neurotransmitter interactions. The model provides a framework for analysing the neurological alterations associated with disorders of the basal ganglia and their treatment with pharmacotherapies affecting dopamine and glutamate neurotransmitter systems.


Subject(s)
Corpus Striatum/drug effects , Corpus Striatum/physiology , Dopamine/metabolism , Glutamic Acid/metabolism , Animals , Cocaine/administration & dosage , Corpus Striatum/cytology , Neurons/drug effects , Neurons/physiology , Picrotoxin/administration & dosage , Rats , Rats, Sprague-Dawley , Receptors, Dopamine D1/metabolism , Receptors, Glutamate/metabolism , Signal Transduction/drug effects , Signal Transduction/physiology , Stereotyped Behavior/drug effects , Stereotyped Behavior/physiology
15.
J Inorg Biochem ; 87(1-2): 63-9, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11709215

ABSTRACT

Aluminium (Al) is a neurotoxicant and appears as a possible etiological factor in Alzheimer's disease and other neurological disorders. The mechanisms of Al neurotoxicity are presently unclear but evidence has emerged suggesting that Al accumulation in the brain can alter neuronal signal transduction pathways associated with glutamate receptors. In cerebellar neurons in culture, long term-exposure to Al added 'in vitro' impaired the glutamate-nitric oxide (NO)-cyclic GMP (cGMP) pathway, reducing glutamate-induced activation of NO synthase and NO-induced activation of the cGMP generating enzyme, guanylate cyclase. Prenatal exposure to Al also affected strongly the function of the glutamate-NO-cGMP pathway. In cultured neurons from rats prenatally exposed to Al, we found reduced content of NO synthase and of guanylate cyclase, and a dramatic decrease in the ability of glutamate to increase cGMP formation. Activation of the glutamate-NO-cGMP pathway was also strongly impaired in cerebellum of rats chronically treated with Al, as assessed by in vivo brain microdialysis in freely moving rats. These findings suggest that the impairment of the Glu-NO-cGMP pathway in the brain may be responsible for some of the neurological alterations induced by Al.


Subject(s)
Aluminum/toxicity , Brain/drug effects , Cyclic GMP/metabolism , Glutamic Acid/metabolism , Neurons/drug effects , Nitric Oxide/metabolism , Animals , Brain/cytology , Brain/pathology , Female , Humans , Neurons/metabolism , Pregnancy , Prenatal Exposure Delayed Effects , Signal Transduction/drug effects
17.
Pharmacol Biochem Behav ; 67(1): 161-8, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11113496

ABSTRACT

The contribution made by specific dopamine receptor subtypes to the induction of motor behaviors has not been firmly established. Here, we first characterized the behavioral effects induced by a D(2)-class receptor agonist, bromocriptine, following injections into the nucleus accumbens (Acb). Bromocriptine showed an atypical D(2)-class receptor agonist profile, having no observable effect on a range of motor behaviors. However, when coadministered with the D(1)-class receptor agonist SKF 38393, bromocriptine showed a typical D(2)-class receptor agonist profile, enhancing locomotor activity and suppressing spontaneous yawning. We then administered the dopamine receptor antagonists L-741626 and nafadotride, which possess relative selectivity for D(2) and D(3) receptors, respectively, prior to injections of dopamine agonists into the Acb. Nafadotride significantly reduced the locomotor-enhancing effects elicited by the coadministration of SKF 38393 and the D(2)-class receptor agonist (+)-PD 128907 into the Acb, and also attenuated the effects induced by the combination of SKF 38393 and bromocriptine, although not significantly so. L-741626 mildly attenuated the locomotor effects elicited by both drug combinations. Taken together, these results suggest that both D(2) and D(3) receptors in the Acb contribute to the expression of heightened psychomotor activation.


Subject(s)
Behavior, Animal/drug effects , Motor Activity/drug effects , Nucleus Accumbens/drug effects , Receptors, Dopamine D2/drug effects , 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology , Animals , Benzopyrans/pharmacology , Bromocriptine/pharmacology , Grooming/drug effects , Indoles/pharmacology , Naphthalenes/pharmacology , Oxazines/pharmacology , Piperidines/pharmacology , Pyrrolidines/pharmacology , Rats , Rats, Wistar , Receptors, Dopamine D1/drug effects , Receptors, Dopamine D3
18.
Trends Neurosci ; 23(10 Suppl): S71-7, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11052223

ABSTRACT

The basal ganglia are thought to modulate the release or inhibition of movements by way of direct and indirect pathways that act as a push-pull system of cortico-basal ganglia circuits. Here we suggest a three-pathway model of the basal ganglia that takes into consideration the fundamental division of the striatum into striosomes and extrastriosomal matrix. We suggest that, in addition to the balance between direct and indirect pathways on which normal release of individual movements depends, the balance of activity between these matrix-based pathways and the striosomal pathway regulates the frequency of release of given behavioral sequences and, thus, modulates behavioral focus. Differential plasticity in these compartmentally organized circuits might contribute to the development of L-dopa-induced dyskinesias under parkinsonian conditions and dopamine-receptor-agonist induced stereotypies under normal conditions.


Subject(s)
Antiparkinson Agents/adverse effects , Basal Ganglia/metabolism , Cerebral Cortex/metabolism , Dopamine/metabolism , Dyskinesia, Drug-Induced/metabolism , Levodopa/adverse effects , Stereotypic Movement Disorder/metabolism , Animals , Basal Ganglia/drug effects , Cerebral Cortex/drug effects , Dyskinesia, Drug-Induced/etiology , Humans , Models, Neurological , Neural Pathways/drug effects , Neuronal Plasticity/drug effects , Stereotypic Movement Disorder/chemically induced
19.
Synapse ; 36(4): 297-306, 2000 Jun 15.
Article in English | MEDLINE | ID: mdl-10819907

ABSTRACT

Many neurochemical and behavioral functions mediated by dopamine require the dynamic interaction between dopamine receptors. We examined the behavioral effects evoked by microinjections of drugs with relative selectivity for specific dopamine receptors into the nucleus accumbens (Acb). The results showed that, at behaviorally inactive doses, the dopamine D1-class receptor agonist SKF 38393 switched the behavioral profile induced by injections of the dopamine D2-class receptor agonist quinpirole into the Acb, from sedation, yawning, and motor inhibition to hyperactive-like behavior. Further, the effects of injections of the dopamine D2-class receptor agonist (+)-PD 128907 into the shell of Acb, including suppression of rearing, locomotion, and grooming, and induction of oral dyskinesia, yawning, and sedation, could not be distinguished from those elicited by (+)-PD 128907 following infusions into the core of Acb. However, the behavioral effects elicited by coadministration of SKF 38393 and (+)-PD 128907 into the core or the shell of Acb showed a striking anatomical specificity. The infusion of SKF 38393 plus (+)-PD 128907 into the core, but not into the shell, of Acb modified the pattern of responses induced by (+)-PD 128907, inducing behavioral hyperactivity. These results suggest critical differences in the functional interaction between dopamine receptors in the core and the shell of the Acb and reveal a mechanism of behavioral switching in the core of Acb by virtue of which dopamine D1-class receptors regulate the transition from states of behavioral suppression to states of heightened psychomotor arousal.


Subject(s)
Behavior, Animal/physiology , Grooming/physiology , Motor Activity/physiology , Nucleus Accumbens/metabolism , Receptors, Dopamine/physiology , 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology , Animals , Behavior, Animal/drug effects , Benzopyrans/pharmacology , Dopamine Agonists/pharmacology , Dyskinesia, Drug-Induced/physiopathology , Grooming/drug effects , Motor Activity/drug effects , Oxazines/pharmacology , Rats , Rats, Wistar
20.
Ann Neurol ; 47(4 Suppl 1): S53-9, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10762132

ABSTRACT

Chronic administration of drugs that increase dopaminergic neurotransmission produces long-lasting changes in gene regulation and behavior. Evidence suggests that several conditions in which the serial ordering and coordination of motor actions are disrupted following dopaminergic treatment share common underlying neurobiological mechanisms. The induction of high-intensity motor stereotypies by dopamine D1- and D2-class receptor agonists, the sensitized behavioral responsiveness to psychostimulant drugs in normal animals, and the progressive sensitization of dyskinesias after intermittent treatment with dopamine agonists following dopamine depletion are all correlated with persistent changes in gene induction in the striatum. These changes, as measured by the induction of immediate-early genes, consist of a relative enhancement in the autoregulatory activity of the striosomal pathway and the disinhibitory activity of the direct output pathway. We hypothesize that long-term modifications in the activity of these pathways result in persistent adaptations in striatum-centered motor loops linking the basal ganglia and cortex, as well as long-lasting disruption of the timing and segmentation of motor behavior.


Subject(s)
Dopamine Agents/administration & dosage , Dopamine/genetics , Dyskinesia, Drug-Induced/genetics , Levodopa/administration & dosage , Parkinson Disease/drug therapy , Brain Chemistry/drug effects , Brain Chemistry/genetics , Dopamine Agents/adverse effects , Gene Expression/drug effects , Humans , Levodopa/adverse effects , Parkinson Disease/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...